BioPharma Dive April 29, 2024
Sponsors and clinical researchers have been voicing a desire to adopt patient-centric approaches to drug development for more than a decade, but most clinical trials are still designed the same way they were before the industry began tentatively pursuing this model. If our industry is to truly enhance the patient experience and improve population health outcomes, we need to go beyond incremental efforts at innovation—such as inviting members of patient advocacy groups to provide input on clinical trial plans—and instead embark upon a full-scale paradigm shift.
No healthcare encounter ever takes place in a vacuum. To better address the social, environmental and cultural factors that prevent patients from achieving the best possible health outcomes, we need more collaboration across sectors...
Today's Sponsors
Today's Sponsor